Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience - 01/09/21
Doi : 10.1016/j.accpm.2021.100889
Thomas Geeraerts a, b, ⁎ 
, François Montastruc c, d, Fabrice Bonneville b, e, Vincent Mémier f, Nicolas Raposo b, g
, François Montastruc c, d, Fabrice Bonneville b, e, Vincent Mémier f, Nicolas Raposo b, gToulouse Vitt Study Group**
Jean Darcourt h, Maxime Pommier i, Fanny Vardon-Bounes i, Muriel Alvarez j, Jacques Izopet k, Sophie Voisin l, Pierre Sié l, Franck Roux m, Jean Marc Olivot n, Jean-François Albucher n
h Department of Neuroradiology, Toulouse University Hospital, University Toulouse 3-Paul Sabatier, Toulouse, France
i Department of Anaesthesiology and Critical Care, Toulouse University Hospital, University Toulouse 3-Paul Sabatier, Toulouse, France
j Department of Tropical and Infectious Diseases, Toulouse University Hospital, University Toulouse 3-Paul Sabatier, Toulouse, France
k Department of Virology, Toulouse University Hospital, University Toulouse 3-Paul Sabatier, INSERM UMR1043/CNRS UMR5282, Centre for Pathophysiology of Toulouse Purpan, France
l Haematology Laboratory, Toulouse University Hospital, University Toulouse 3-Paul Sabatier, Toulouse, France
m Department of Neurosurgery, Toulouse University Hospital, University Toulouse 3-Paul Sabatier, Toulouse, France
n Department of Neurology, Toulouse University Hospital, University Toulouse 3-Paul Sabatier, Toulouse, France
a Department of Anaesthesiology and Critical Care, Toulouse University Hospital, University Toulouse 3-Paul Sabatier, Toulouse, France
b Toulouse Neuroimaging Center (Tonic), University Paul Sabatier, INSERM, Toulouse, France
c Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital (CHU), Faculty of Medicine, Toulouse, France
d CIC 1436, Team PEPSS « Pharmacologie En Population cohorteS et biobanqueS », Toulouse University Hospital, France
e Department of Neuroradiology, Toulouse University Hospital, University Toulouse 3-Paul Sabatier, Toulouse, France
f Haematology Laboratory, Toulouse University Hospital, University Toulouse 3-Paul Sabatier, Toulouse, France
g Department of Neurology, Toulouse University Hospital, University Toulouse 3-Paul Sabatier, Toulouse, France
⁎Corresponding author at: Coordination d’Anesthésie, CHU Toulouse, Hôpital Pierre Paul Riquet, 31059 Toulouse, France.Coordination d’AnesthésieCHU ToulouseHôpital Pierre Paul RiquetToulouse31059France
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2021
Société française d'anesthésie et de réanimation (Sfar). Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 40 - N° 4
Articolo 100889- Agosto 2021 Ritorno al numero
Articolo precedente
- Preliminary data on severe SARS-CoV-2 infection caused by the 501Y.V2 variant
- Guillaume Louis, Christophe Goetz, Nouchan Mellati, Paul Dunand, Yoann Picard
- Non-invasive oxygenation strategies for respiratory failure with COVID-19: A concise narrative review of literature in pre and mid-COVID-19 era
- Kenta Ogawa, Kengo Asano, Junpei Ikeda, Tomoko Fujii
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.